Type 2-diabetes mellitus(T2DM) is a progressive disease associated with significant morbidity and mortality. Glucagon like peptide-1(GLP-1) is an i ncretin hormone secreted from the small intestine that lowers fasting and postprandial glucose through multiple mechanisms including glucose- dependent insulin secretion, reduction of glucagon secretion, delaying gastric emptying and increased satiety[1-4]
